Literature DB >> 17653766

Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.

Jelena Sopta1, Aleksandar Dordević, Goran Tulić, Vesna Mijucić.   

Abstract

BACKGROUND: Dedifferentiated chondrosarcoma represents a special form of the chondrosarcoma characterized by the presence of well-differentiated cartilaginous component in juxtaposition with the malignant mesenchymal tumor of high-malignancy grade.
METHODS: The study was performed on 25 tissue samples obtained by biopsy of the primary malignant bone tumors.
RESULTS: Out of the total of 25 patients, 13 were males and 12 were females. Their average age was 59.9 years (39-75). Radiological examination verified the presence of the pathological fractures in 14 patients. The skeletal distribution clearly indicates that the femur is the most frequent site of affection (in 15 patients--60%). Morphological analysis verified the presence of "precursor cartilaginous lesion" or low-grade cartilaginous component in all cases. Classification of the high-grade components was based on the immunohistochemical analyses, which evidenced MFH in 18 cases, osteosarcoma in 4, while fibrosarcoma was evidenced in 2 and rhabdomyosarcoma in 1 case. In 20 patients, out of whom 14 had existing fractures, amputation was indicated. In five patients (fracture-free), resection limb-salvage surgical intervention was performed.
CONCLUSION: The lethal outcome ensues within less than 2 years in all patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653766     DOI: 10.1007/s00432-007-0262-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy.

Authors:  A Saifuddin; B S Mann; S Mahroof; J A S Pringle; T W R Briggs; S R Cannon
Journal:  Clin Radiol       Date:  2004-03       Impact factor: 2.350

2.  Dedifferentiated central chondrosarcoma.

Authors:  Eric L Staals; Patrizia Bacchini; Franco Bertoni
Journal:  Cancer       Date:  2006-06-15       Impact factor: 6.860

3.  H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.

Authors:  A Sakamoto; Y Oda; T Adachi; Y Oshiro; S Tamiya; K Tanaka; S Matsuda; Y Iwamoto; M Tsuneyoshi
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

4.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

Review 5.  Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.

Authors:  Judith V M G Bovée; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

6.  Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.

Authors:  Ian D Dickey; Peter S Rose; Bruno Fuchs; Lester E Wold; Scott H Okuno; Franklin H Sim; Sean P Scully
Journal:  J Bone Joint Surg Am       Date:  2004-11       Impact factor: 5.284

Review 7.  Chondrosarcoma of the pelvis. A review of sixty-four cases.

Authors:  M E Pring; K L Weber; K K Unni; F H Sim
Journal:  J Bone Joint Surg Am       Date:  2001-11       Impact factor: 5.284

Review 8.  Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.

Authors:  T Aigner
Journal:  Virchows Arch       Date:  2002-05-01       Impact factor: 4.064

9.  The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component.

Authors:  Wojciech Rzeszutko; Piotr Dziegiel; Marta Rzeszutko; Andrzej Wojnar
Journal:  Folia Morphol (Warsz)       Date:  2003-11       Impact factor: 1.183

10.  Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma.

Authors:  M Röpke; C Boltze; H W Neumann; A Roessner; R Schneider-Stock
Journal:  Pathol Res Pract       Date:  2003       Impact factor: 3.250

View more
  5 in total

1.  Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.

Authors:  Rieko Oyama; Fusako Kito; Mami Takahashi; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Rei Noguchi; Takashi Kubo; Shunichi Toki; Fumihiko Nakatani; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2019-02-08       Impact factor: 4.174

Review 2.  The clinical management of chondrosarcoma.

Authors:  Richard F Riedel; Nicole Larrier; Leslie Dodd; David Kirsch; Salutario Martinez; Brian E Brigman
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

3.  Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.

Authors:  Isidro Machado; Francisco Giner; Empar Mayordomo; Carmen Carda; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

4.  Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients.

Authors:  Chenglei Liu; Yan Xi; Mei Li; Qiong Jiao; Huizhen Zhang; Qingcheng Yang; Weiwu Yao
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.

Authors:  Lei Cao; Yuan Wu; Shu-Man Han; Tao Sun; Bao-Hai Yu; Feng Gao; Wen-Juan Wu; Bu-Lang Gao
Journal:  BMC Musculoskelet Disord       Date:  2021-02-15       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.